(Q53112985)

11 May 2018

title

Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. (English)

1 reference

11 May 2018

author name string

Michael T Tetzlaff

1

1 reference

11 May 2018

Jonathan L Curry

2

1 reference

11 May 2018

Doina Ivan

3

1 reference

11 May 2018

Wei-Lien Wang

4

1 reference

11 May 2018

Carlos A Torres-Cabala

5

1 reference

11 May 2018

Roland L Bassett

6

1 reference

11 May 2018

Karla M Valencia

7

1 reference

11 May 2018

Michael S McLemore

8

1 reference

11 May 2018

Merrick I Ross

9

1 reference

11 May 2018

Victor G Prieto

10

1 reference

11 May 2018

publication date

5 April 2013

1 reference

11 May 2018

published in

Modern Pathology

1 reference

11 May 2018

volume

26

1 reference

11 May 2018

issue

9

1 reference

11 May 2018

page(s)

1153-1160

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.59

exact match

0 references

cites work

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Sentinel-lymph-node biopsy for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Histone Phosphorylation and Chromatin Structure during Mitosis in Chinese Hamster Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

H3 phosphorylation: dual role in mitosis and interphase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Level of phosphohistone H3 among various types of human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

A novel immunohistochemical method to estimate cell‐cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

Sentinel lymph node biopsy in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

7 January 2021

The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

7 January 2021

Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

7 January 2021

Immunohistochemical assessment of mitotic count in uveal melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

7 January 2021

Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

7 January 2021

Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

7 January 2021

H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.59

7 January 2021

10.1038/MODPATHOL.2013.59

Identifiers

DOI

1 reference

11 May 2018

Dimensions Publication ID

1040016896

0 references

1 reference

11 May 2018